Skip to content

Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases

Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02317172
Enrollment
120
Registered
2014-12-15
Start date
2012-10-31
Completion date
2013-03-31
Last updated
2014-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Hypertension, Xerostomia

Keywords

Saliva substitute, Edible gel, Xerostomia, Diabetes Mellitus, Hypertension

Brief summary

Elderly people usually have systemic diseases and take medications that can cause dry mouth. The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in geriatric population with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.

Detailed description

A pre-post test trial was conducted in 120 elders with xerostomia. All subjects received a total of 50 ml (10ml x 5 times) OMJ per day. Subjective and objective dry mouth scores, salivary pH, buffering capacity and satisfaction were monitored at 2 weeks and 1 month use, compared to baseline. The data were analyzed by Repeated Measure ANOVA.

Interventions

Gel-based artificial saliva is a novel gel-like, edible moisturizing gel designed to relieve dry mouth.

Sponsors

Thammasat University
CollaboratorOTHER
Srinakharinwirot University
CollaboratorOTHER
Mahidol University
CollaboratorOTHER
Ministry of Health, Thailand
CollaboratorOTHER_GOV
Dental Innovation Foundation Under Royal Patronage
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have systemic diseases such as hypertension or diabetes mellitus and take medications that can cause dry mouth * Report symptoms of dry mouth

Exclusion criteria

* Subjects with uncontrolled systemic diseases * Subjects who aspirate upon eating * Subjects who smoke * Subjects who are allergic to component of the intervention

Design outcomes

Primary

MeasureTime frameDescription
Changes in subjective dry mouth scorebaseline, 2 weeks and 4 weeks after interventionThe outcome measure (subjective dry mouth score) will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)

Secondary

MeasureTime frameDescription
Changes in objective dry mouth scorebaseline, 2 weeks and 4 weeks after interventionThe outcome measure will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)
Changes in salivary Potential of Hydrogen ion (pH)baseline, 2 weeks and 4 weeks after interventionThe outcome measure will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)
Changes in salivary buffering capacitybaseline, 2 weeks and 4 weeks after interventionThe outcome measure will be measured before and 2 and 4 weeks after continuous usage of edible gel-based artificial saliva (30-50 ml/day for at least 5 days per week)
Satisfaction of the edible gel-based artificial salivaat the first day of trialAll subjects will try a few spoon of the edible gel based saliva and a commercially available inedible gel-based saliva. Then, all subjects will be interviewed for satisfaction of both products and compare the results.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026